CID 135468108

Pyridazinone derivative, 8i

Structural Information

Molecular Formula
C22H23N5O7S2
SMILES
CC(C)CCN1C(=O)C(=C(C(=N1)C2=CC=CS2)O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)OCC(=O)NO
InChI
InChI=1S/C22H23N5O7S2/c1-12(2)7-8-27-22(30)18(20(29)19(24-27)15-4-3-9-35-15)21-23-14-6-5-13(34-11-17(28)25-31)10-16(14)36(32,33)26-21/h3-6,9-10,12,29,31H,7-8,11H2,1-2H3,(H,23,26)(H,25,28)
InChIKey
QQQNUPKTFJRVEI-UHFFFAOYSA-N
Compound name
N-hydroxy-2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-ylpyridazin-4-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]oxy]acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

4
Patents

533.1039 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 534.11118 213.5
[M+Na]+ 556.09312 220.7
[M-H]- 532.09662 215.4
[M+NH4]+ 551.13772 216.5
[M+K]+ 572.06706 214.2
[M+H-H2O]+ 516.10116 206.6
[M+HCOO]- 578.10210 216.8
[M+CH3COO]- 592.11775 238.6
[M+Na-2H]- 554.07857 214.0
[M]+ 533.10335 219.4
[M]- 533.10445 219.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe